Valutazione dell'utilizzo di acido tranexamico nelle osteotomie tibiali: Studio clinico randomizzato controllato

Title

Code

TXA-HTO

Type

Sperimentale

Start Year

2021

Status

In Corso

Principal Investigator

051-6366111 (centralino)

stefano.zaffagnini@unibo.it

Zaffagnini Stefano, MD

Director

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. TXA-HTO

Thursday 11 August 2022, 13:55

PG0002014_2021_TXA-HTO.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

IRCCS

ISTITUTO ORTOPEDICO RIZZOLI

Valutazione dell'utilizzo di acido tranexamico nelle osteotomie tibiali: Studio clinico randomizzato controllato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Sito Web Istituto Ortopedico Rizzoli

Valutazione dell'utilizzo di acido tranexamico nelle osteotomie tibiali: Studio clinico randomizzato controllato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in